Teva Pharmaceuticals Scholars Grants
The Teva Pharmaceuticals Scholars grants program is administered by the ACS Office of Research Grants with funding provided by Teva Pharmaceuticals. The program is a philanthropic grant program that supports academic researchers in the fields of organic and medicinal chemistry.
Teva Pharmaceuticals Symposium 2012
The Inaugural Teva Pharmaceuticals Symposium was held at the 244th National Meeting & Exposition of the American Chemical Society (ACS) on August 21, 2012. The event was co-sponsored by The ACS Board Standing Committee on Grants and Awards and the ACS Division of Organic Chemistry, and included an intermission reception hosted by Teva Pharmaceuticals. The (2009-2012) Teva Pharmaceuticals Scholars awardees described discoveries on anti-cancer drugs made from antibiotics, a potential new drug for hepatitis C and a new approach for delivering drugs to the body.
Amount: $100,000 per year for 3 years
Number of awards: 3
Award period: September 1, 2015 to August 31, 2018
An applicant must be a recently-tenured faculty member of a PhD-granting department in the United States. Read more about Eligibility, Terms, and Conditions for Teva Pharmaceuticals Scholars Grants.
Research Area and Evaluation Criteria
Applications for the Teva Pharmaceuticals Scholars grants must propose research in the area of organic chemistry, with potential or direct connections with medicinal or pharmaceutical chemistry, such that the successful results would be of potential practical benefit to the discovery of organic compounds useful as human medicines. Proposals are evaluated on: a) scientific merit, creativity and novelty; and b) addressing unexplored fields in organic and/or medicinal chemistry. General aspects of research proposals will also be considered, such as: Is the project achievable within the time frame? Are the personnel and facilities adequate? Does the applicant consider and address potential problems?
The following budget restrictions apply:
No institutional overhead charges, nor facilities and adminsistrative charges will be charged to the grant nor will any be provided by ACS-Teva.
Applications will include a budget in the amount of $100,000 for each of three years (Total = $300,000) with the following categories: personnel (multiple categories – below); reagents and expendables; permanent equipment; travel. A brief budget explanation should be part of the proposal; budget considerations may be part of the evaluation of the proposal.
A maximum of $10,000 per year may be used to support the principal investigator’s salary, including benefits. Postdoctoral fellows, research associates, technicians, graduate students (stipend and/or tuition), and/or undergraduate students may be supported through the grant, at levels commensurate with the grantee’s department or academic unit.
A maximum of $5,000 per year may be used for travel, including travel to conferences or symposia, or to collaborating laboratories. Travel to present research results must be budgeted for the third year; see below.
At the end of each grant year, the grantee will submit a financial report (and a scientific progress report; see below). Of the support given, funds remaining at the end of each grant year may be carried forward into the next.
Each grant recipient is required to submit annual scientific progress and financial reports to the ACS Office of Research Grants. ACS shall, in its sole discretion and consistent with its standard practices, determine whether the grant recipient is meeting the goals and objectives appropriately.
Each grant recipient is required to present a lecture during or promptly following the grant period at a time and place to be agreed upon by the grant recipient and the ACS. Recipients’ travel costs in connection with the lecture should be budgeted in travel for the third year.
We are no longer accepting proposals at this time. The deadline for receipt of applications was 5:00 p.m. ET Friday, May 1, 2015.
Teva Pharmaceuticals Scholars (2012-2015)
Past TEVA Grantees
Teva Pharmaceuticals Scholars in the News
Teva Scholar Dr. Phil S. Baran receives award recognition for his significant contributions to science. Read more
Dr. Nancy Jensen